Company news

Syntara Limited news in 2022

Syntara Limited's news releases, calls and decks from 2022, newest first.

View company

PXS announces positive interim data from myelofibrosis trial

October 18, 2022

Investor Presentation

October 18, 2022

PXS Releases Promising Interim Data from Skin Scarring Study

September 25, 2022

PXS to Receive Stg2.9m from Parkinsons UK for New Trial

August 31, 2022

Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology

August 4, 2022

Clarification Announcement

May 13, 2022

Appendix 4C Quarterly Cash Flow Report

April 28, 2022

Response to ASX Aware Query

January 10, 2022

PXS Collaborators Receive Government Grants of $1.4m

January 5, 2022

Decks in 2022